For many years our service at the Timone Hospital has collaborated with researchers including the " Natural Killer Cells and Innate Immunity" team of Eric VIVIER .
As a an internal medicine physician, I am often faced with patients who have conditions that result from immune system dysfunctions. These inflammatory or autoimmune diseases are often rare diseases whose causes and symptoms are misunderstood: lupus, myositis autoimmune diseases, immune deficiencies in adults, systemic fibrosis, etc.
Like Marseille Immunopole, our discipline is positioned at the interface of different medical specialties, but also of fundamental and translational research. For many years our service at the Timone Hospital has collaborated with researchers including the ” Natural Killer Cells and Innate Immunity” team of Eric VIVIER at CIML. Together, we have developed a laboratory at the Conception Hospital specializing in the functional exploration of these lymphocytes and rare lymphocyte populations. We are conducting studies to better understand their involvement in diseases such as Systemic Lupus Erythematosus, Immune Thrombocytopenia Purpura (ITP) or IgG4-related diseases. The laboratory has also developed a routine battery of tests to quantify and qualify the activity of NK cells, T helper cells (Th) and Innate Lymphoid Cells (ILCs), particularly in clinical trials.#clinique
The laboratory's mission therefore reflects that of the Marseille Immunopôle: to lead the development of these innovations, from the initial discovery to the proof of concept in clinical setting.
Education is also one of the strategic components of the Marseille Immunopole project
AMU, AP-HM, VRCM
Thanks to this unprecedented alliance of researchers, clinicians, technological platforms and industrials we should be able to quickly do much better
“Our immunotherapy antibodies are positioned at the crossroads of two immunology fields with high potential: the g9d2 T cells and a novel superfamily of immunomodulators, butyrophilins”